Aspira Pathlab & Diagnostics Limited reported unaudited earnings results for the quarter ended June 30, 2021. For the quarter, the company reported total income of INR 59.060 million against INR 15.907 million a year ago. Total comprehensive income was INR 20.034 million or INR 1.95 per basic and diluted share against loss of INR 6.299 million or INR 0.68 per basic and diluted share a year ago.